PROCEPT BioRobotics Income Statement (2020-2025) | PRCT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 2.11M3.22M7.19M8.48M8.67M10.14M14.20M16.69M20.35M23.78M24.40M33.10M35.10M43.58M44.54M53.35M58.37M68.24M69.16M79.18M83.33M
Cost of Revenue 2.14M2.75M3.67M4.89M4.43M5.62M6.50M8.21M10.12M13.10M11.91M14.68M16.23M22.33M19.50M21.87M21.46M24.56M25.00M27.44M29.32M
Gross Profit -0.03M0.47M3.53M3.58M4.24M4.52M7.69M8.49M10.23M10.68M12.49M18.43M18.87M21.25M25.03M31.48M36.91M43.67M44.16M51.75M54.01M
Operating items
Research & Development 3.89M4.54M4.52M4.48M4.92M5.08M5.01M6.71M7.58M9.68M10.74M11.61M11.60M14.50M13.08M17.50M16.65M15.07M16.40M17.63M18.19M
Selling, General & Administrative 7.05M9.13M10.35M12.30M12.12M16.27M18.39M19.66M24.75M26.03M30.13M32.44M32.88M36.32M39.60M40.81M42.69M48.32M55.20M56.30M59.01M
Operating Expenses 10.95M13.68M14.87M16.77M17.04M21.35M23.40M26.36M32.34M35.72M40.87M44.05M44.48M50.81M52.68M58.31M59.34M63.38M71.60M73.94M77.20M
Operating Income -10.98M-13.21M-11.34M-13.19M-12.80M-16.83M-15.70M-17.88M-22.11M-25.04M-28.38M-25.62M-25.61M-29.56M-27.65M-26.83M-22.43M-19.71M-27.44M-22.19M-23.19M
EBIT -10.98M-13.21M-11.34M-13.19M-12.80M-16.83M-15.70M-17.88M-22.11M-25.04M-28.38M-25.62M-25.61M-29.56M-27.65M-26.83M-22.43M-19.71M-27.44M-22.19M-23.19M
Non-operating items
Interest & Investment Income 0.36M-0.30M-0.01M0.05M0.16M-0.08M-0.06M0.13M0.95M0.99M0.78M1.30M2.01M3.18M2.74M2.23M2.59M1.82M3.58M3.51M2.70M
Net income details
EBT -12.01M-15.28M-12.82M-14.58M-14.10M-18.35M-17.18M-19.18M-22.61M-24.91M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M
Profit After Tax -12.01M-15.28M-12.82M-14.58M-14.10M-18.35M-17.18M-19.18M-22.61M-28.17M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M
Income from Continuing Operations -12.01M-15.28M-12.82M-14.58M-14.10M-18.35M-17.18M-19.18M-22.61M-24.91M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M
Consolidated Net Income -12.01M-15.28M-12.82M-14.58M-14.10M-18.35M-17.18M-19.18M-22.61M-24.91M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M
Income towards Parent Company -12.01M-15.28M-12.82M-14.58M-14.10M-18.35M-17.18M-19.18M-22.61M-24.91M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M
Net Income towards Common Stockholders -12.01M-15.28M-12.82M-14.58M-14.10M-18.35M-17.18M-19.18M-22.61M-24.91M-28.48M-25.29M-24.62M-27.50M-25.96M-25.63M-20.97M-18.86M-24.74M-19.58M-21.41M
Additional items
EPS (Basic) -2.77-3.13-2.65-2.60-1.222.01-0.39-0.43-0.51-0.63-0.63-0.56-0.51-0.54-0.51-0.50-0.40-0.36-0.45-0.35-0.38
EPS (Weighted Average and Diluted) -2.77-3.13-2.65-2.60-1.222.01-0.39-0.43-0.51-0.63-0.63-0.56-0.51-0.54-0.51-0.50-0.40-0.36-0.45-0.35-0.38
Shares Outstanding (Weighted Average) 4.33M3.66M4.83M5.60M11.58M16.48M43.85M44.32M44.64M44.40M45.07M45.16M48.31M47.26M51.01M51.62M52.01M52.12M54.92M55.45M55.73M
Shares Outstanding (Diluted Average) 4.33M3.66M4.83M5.60M11.58M16.48M43.85M44.32M44.64M44.40M45.07M45.16M48.31M47.26M51.01M51.62M52.01M52.12M54.92M55.45M55.73M
EBITDA -12.02M-15.30M-12.84M-14.59M-14.11M-18.36M-17.18M-19.10M-22.43M-28.39M-28.46M-25.31M-24.62M-27.41M-25.93M-25.74M-20.99M-18.72M-24.63M-19.95M-21.23M
Interest Expenses 1.39M1.77M1.46M1.44M1.47M1.44M1.42M1.44M1.46M0.87M0.89M0.96M1.02M1.12M1.04M1.03M1.14M0.97M0.88M0.90M0.92M